Skip to content

Epidemiological Analysis of Vitamin D and Breast Cancer Risk in Saudi Arabian Women

Vitamin D Status and Breast Cancer in Saudi Arabian Women: Case Control Study

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT01817231
Enrollment
240
Registered
2013-03-25
Start date
2009-05-31
Completion date
2009-08-31
Last updated
2013-03-25

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Breast Cancer, Vitamin D Deficiency

Keywords

breast cancer, vitamin D, 25 OH vitamin D

Brief summary

This is an analysis of de-identified data collected from 240 Saudi Arabian women, 120 with breast cancer and 120 control women, to evalyate if vitamin D status is associated with breast cancer risk.

Detailed description

Background: The role of vitamin D in breast cancer prevention is equivocal. Saudi Arabian women are thought to be at greater risk for vitamin D deficiency due to darker skin type and greater likelihood for reduced UVB radiation exposure. However, there is a lack of data regarding the vitamin D status of Saudi Arabian women and how this may relate to breast cancer risk. Objective: The purpose of this research was to evaluate the association between circulating concentrations of 25(OH)D and breast cancer risk in Saudi Arabian women. Design: A case-control study was conducted among 120 breast cancer cases and 120 controls. The study population was drawn from patients admitted to King Fahd Hospital in Jeddah, Saudi Arabia from June to August 2009. Participants completed questionnaires on diet and medical history and serum samples were collected from all women to measure circulating 25(OH)D concentrations.

Interventions

None listed

Sponsors

University of Arizona
Lead SponsorOTHER

Study design

Observational model
CASE_CONTROL
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
FEMALE
Age
18 Years to 75 Years
Healthy volunteers
Yes

Inclusion criteria

* Invasive breast cancer (cases) or healthy women (controls), * receiving standard medical check-ups at the women's clinic * Female, * between the ages of 18 and 75 years * BMI ≤ 40 kg/m2 * residence in Saudi Arabia for more than 5 years * absence of chronic diseases that could affect vitamin D metabolism, including renal, hepatic, endocrine, or autoimmune disease.

Exclusion criteria

receiving standard medical check-ups at the women's clinic * Male, * less than 18 or greater than 75 years of age * BMI \> 40 kg/m2 * Not a resident of Saudi Arabia for more than 5 years * Presence of chronic diseases that could affect vitamin D metabolism, including renal, hepatic, endocrine, or autoimmune disease.

Design outcomes

Primary

MeasureTime frameDescription
serum vitamin Dcross-sectional from May 2009-August 2009assessed serum vitamin D in cases versus controls

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Mar 23, 2026